217 related articles for article (PubMed ID: 37175802)
1. Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima.
Hwang AR; Lee HJ; Kim S; Park SH; Woo CH
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175802
[TBL] [Abstract][Full Text] [Related]
2. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
[TBL] [Abstract][Full Text] [Related]
3. RhoGDI3 at the trans-Golgi network participates in NLRP3 inflammasome activation, VSMC phenotypic modulation, and neointima formation.
Sun J; Zhu Q; Yu X; Liang X; Guan H; Zhao H; Yao W
Atherosclerosis; 2023 Dec; 387():117391. PubMed ID: 38029612
[TBL] [Abstract][Full Text] [Related]
4. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.
Lu QB; Wan MY; Wang PY; Zhang CX; Xu DY; Liao X; Sun HJ
Redox Biol; 2018 Apr; 14():656-668. PubMed ID: 29175753
[TBL] [Abstract][Full Text] [Related]
5. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.
Han JH; Park HS; Lee DH; Jo JH; Heo KS; Myung CS
Life Sci; 2021 Feb; 267():118978. PubMed ID: 33412209
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of scoparone from chestnut inner shell on platelet-derived growth factor-BB-induced vascular smooth muscle cell migration and vascular neointima hyperplasia.
Jung SH; Lee GB; Ryu Y; Cui L; Lee HM; Kim J; Kim B; Won KJ
J Sci Food Agric; 2019 Jul; 99(9):4397-4406. PubMed ID: 30861122
[TBL] [Abstract][Full Text] [Related]
7. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
[TBL] [Abstract][Full Text] [Related]
8. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
[TBL] [Abstract][Full Text] [Related]
9. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
10. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
[TBL] [Abstract][Full Text] [Related]
11. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
[TBL] [Abstract][Full Text] [Related]
12. Gastrodin inhibits cell proliferation in vascular smooth muscle cells and attenuates neointima formation in vivo.
Zhu L; Guan H; Cui C; Tian S; Yang D; Wang X; Zhang S; Wang L; Jiang H
Int J Mol Med; 2012 Nov; 30(5):1034-40. PubMed ID: 22922870
[TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol blocks platelet-derived growth factor-stimulated vascular smooth muscle cell function and reduces neointima formation in vivo.
Guan H; Chen C; Zhu L; Cui C; Guo Y; Fu M; Wang L; Tang Q
J Nutr Biochem; 2013 Jan; 24(1):62-9. PubMed ID: 22784431
[TBL] [Abstract][Full Text] [Related]
14. Compound K, an intestinal metabolite of ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and migration through G1 arrest and attenuates neointimal hyperplasia after arterial injury.
Park ES; Lee KP; Jung SH; Lee DY; Won KJ; Yun YP; Kim B
Atherosclerosis; 2013 May; 228(1):53-60. PubMed ID: 23473423
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane inhibits PDGF-induced proliferation of rat aortic vascular smooth muscle cell by up-regulation of p53 leading to G1/S cell cycle arrest.
Yoo SH; Lim Y; Kim SJ; Yoo KD; Yoo HS; Hong JT; Lee MY; Yun YP
Vascul Pharmacol; 2013; 59(1-2):44-51. PubMed ID: 23810908
[TBL] [Abstract][Full Text] [Related]
16. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
[TBL] [Abstract][Full Text] [Related]
17. AKAP1 alleviates VSMC phenotypic modulation and neointima formation by inhibiting Drp1-dependent mitochondrial fission.
Sun J; Shao Y; Pei L; Zhu Q; Yu X; Yao W
Biomed Pharmacother; 2024 Jul; 176():116858. PubMed ID: 38850669
[TBL] [Abstract][Full Text] [Related]
18. Apigenin attenuates neointima formation via suppression of vascular smooth muscle cell phenotypic transformation.
Guan H; Gao L; Zhu L; Yan L; Fu M; Chen C; Dong X; Wang L; Huang K; Jiang H
J Cell Biochem; 2012 Apr; 113(4):1198-207. PubMed ID: 22095643
[TBL] [Abstract][Full Text] [Related]
19. Insulin-independent GLUT4 translocation in proliferative vascular smooth muscle cells involves SM22α.
Zhao LL; Zhang F; Chen P; Xie XL; Dou YQ; Lin YL; Nie L; Lv P; Zhang DD; Li XK; Miao SB; Yin YJ; Dong LH; Song Y; Shu YN; Han M
J Mol Med (Berl); 2017 Feb; 95(2):181-192. PubMed ID: 27631639
[TBL] [Abstract][Full Text] [Related]
20. Thymoquinone suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation, migration and neointimal formation.
Zhu N; Xiang Y; Zhao X; Cai C; Chen H; Jiang W; Wang Y; Zeng C
J Cell Mol Med; 2019 Dec; 23(12):8482-8492. PubMed ID: 31638340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
